American Shared Hospital Services vs Mangoceuticals
American Shared Hospital Services is the larger business, with $28.1m of revenue in fiscal 2025 against $456,021 for Mangoceuticals (61.6 times as much). American Shared Hospital Services grew faster (-0.9% against -26.0%). American Shared Hospital Services kept more of each dollar of sales as profit: a net margin of -5.5% against -4526.8%. Mangoceuticals carries less debt relative to equity (0.0% against 72.4%).
| Latest fiscal year | American Shared Hospital ServicesAMS, 2025 | MangoceuticalsMGRX, 2025 |
|---|---|---|
| Revenue | $28.1m | $456,021 |
| Revenue growth | -0.9% | -26.0% |
| Net income | −$1.6m | −$20.6m |
| Operating margin | -12.8% | -3954.3% |
| Net margin | -5.5% | -4526.8% |
| Return on equity | -6.3% | -141.6% |
| Free cash flow | −$4.5m | −$5.9m |
| Cash | $3.5m | $1.5m |
| Total debt | $17.4m | $0 |
| Debt to equity | 72.4% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 44 | — |
| Market value | $8.3m | $3.6m |
| Price vs our value range | — | — |
| Moat score | 34 (Weak) | — |
| Insider trades, 12 months | 1 buys, 0 sales | 0 buys, 4 sales |